Richard J. Lewis
Corporate Officer/Principal bei The University of Queensland
Profil
Richard J.
Lewis was the founder of Xenome Ltd.
which was founded in 2000, where he held the title of Chief Scientific Officer from 2000 to 2011.
Currently, he holds the title of Principal at The University of Queensland and National Health & Medical Research Council.
In the past, he held the title of Principal at Molecular Pharmacology (USA) Ltd.
Aktive Positionen von Richard J. Lewis
| Unternehmen | Position | Beginn |
|---|---|---|
| The University of Queensland | Corporate Officer/Principal | 01.07.2009 |
| National Health & Medical Research Council | Corporate Officer/Principal | 01.07.2009 |
Ehemalige bekannte Positionen von Richard J. Lewis
| Unternehmen | Position | Ende |
|---|---|---|
| MOLECULAR PHARMACOLOGY (USA), LTD. | Corporate Officer/Principal | - |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MOLECULAR PHARMACOLOGY (USA), LTD. | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
| National Health & Medical Research Council | Government |
